China Pharma (CPHI) vs Nasus Pharma (NSRX)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 9, 2026.
Summary
Nasus Pharma (NSRX) has outperformed China Pharma (CPHI) over the past year, losing 50.1% versus a loss of 51.8%. Nasus Pharma is the larger company by market cap ($42.5 million vs $41.3 million), about 1.0 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | CPHI | NSRX |
|---|---|---|
| Share price | $0.96 | $3.63 |
| Market cap | $41.30M | $42.52M |
| 1-day change | +12.94% | -3.84% |
| YTD return | -20.66% | -60.33% |
| 1-year return | -51.76% | -50.07% |
| 5-year return | -99.65% | — |
| EPS (TTM) | $-0.42 | $-1.20 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $19.19 | $9.50 |
| 52-week low | $0.38 | $1.98 |
| Distance from 52-week high | -95.00% | -61.79% |
| Analyst consensus | — | buy |
| Avg. price target upside | — | +441.87% |
| Average volume | 5.81M | 16.09K |
| Shares outstanding | 43.02M | 11.71M |
| Employees | 215 | 7 |
| Sector | Healthcare | Healthcare |
| Industry | Drug Manufacturers - Specialty & Generic | Drug Manufacturers - General |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
About China Pharma
CPHI stock →China Pharma Holdings, Inc. develops, manufactures, and markets pharmaceutical products for human use in the People's Republic of China.
Healthcare · Drug Manufacturers - Specialty & Generic · 215 employees
About Nasus Pharma
NSRX stock →Nasus Pharma Ltd., a clinical-stage specialty pharmaceutical company focused on the development of intranasal drugs to treat emergency medical conditions. It offers Powder-Based Intranasal (PBI) products to address acute medical conditions and public health threats.
Healthcare · Drug Manufacturers - General · 7 employees
CPHI vs NSRX FAQ
Which is bigger, China Pharma or Nasus Pharma?
Nasus Pharma (NSRX) is larger, with a market capitalization of $42.52M compared with $41.30M for China Pharma (CPHI).
Which stock has performed better over the past year, CPHI or NSRX?
NSRX returned -50.07% over the past 12 months, compared with -51.76% for CPHI (price return, excluding dividends). Past performance does not predict future results.
Are China Pharma and Nasus Pharma in the same industry?
Both are in the Healthcare sector, but in different industries: Drug Manufacturers - Specialty & Generic for China Pharma and Drug Manufacturers - General for Nasus Pharma.